The treatment of prostate cancer? - New Study Results - delaying treatment of prostate cancer! - Nurses Report

The treatment of prostate cancer? - New Study Results - delaying treatment of prostate cancer! - Nurses Report

Whether or not to treat conventional prostate cancer is one of the great medical dilemmas we have today.Prostate cancer is the most common cancer in American men. Approximately 222,000 cases will be diagnosed this year, though most prostate tumors tend to grow slowly. Never really life threatening. There is no sure way to tell which tumors will grow at a faster rate tests rate.Prostate specific antigen (PSA) can help find tumors many years before they cause symptoms of prostate cancer, though routine screening of men who are at average risk is currently not recommended, because there is no proof that cancer treatments lives.

Prostate saves are particularly strong, especially in older men. And many men end up with after treatment, bladder control sexual or other prostate gland problems or prostate health. Many doctors recommend instead "watchful waiting" to monitor signs of prostate disease and treat only if signs or symptoms worsen. Smaller studies have points contrary to the security of this new view approach.This study observed the natural course of the disease in men who had chosen this option. Grace Lu-Yao of Robert Wood Johnson Medical School in New Jersey was responsible for the study. It is the first study involving many older men. 50% of men were over 75 and many of their tumors found through PSA tests.

As data from this study of prostate cancer in the U.S. government were used. The researchers studied 9,017 men who were diagnosed over a ten year period 1992-2002, with prostate cancer who received early therapy prostate surgery, radiation or hormone for at least six months. Most men had no treatment whatsoever.Ten years later, only 3 percent to 7 percent of patients with low-grade tumors or moderate (that are valued by the aggressiveness of the cells appear to be ) had died of prostate cancer, while 23 percent of patients with high-grade tumors died. Overall, prostate cancer killed only 10 percent of the patients.It 's believed that the majority of patients will die of something else and why most older men with early-stage tumors can delay any treatment. It is not clear what should be done, if at all - in the case of conventional prostate cancer, surgery, radiation and hormone therapy or alternative treatment of prostate cancer. This may be true even if people are younger or have a more advanced prostate cancer. 

 Most cases are diagnosed in men who are 68 years or more, and most are in early stage.In any event this large study shows that a large number of men who do well without initial treatment without long-term treatment . So this new study shows that older men observation is a reasonable approach. Many patients do well for a long period of time without any treatment.To summary, older men with prostate cancer in early stage are not taking a big risk if you just keep an eye on progress rather than go ahead treatment. It is the largest study to look at this issue from the PSA blood test to detect prostate tumors became so popular in the 1990s.The study may persuade some means-the-road prostate doctors are over-treating prostate cancer and the PSA test can we magnifying the problem. Finally, patients have the opportunity to focus on the adoption of a healthy lifestyle and most importantly adopt a healthy diet